Buprenorphine Hydrochloride Tablet
Product Images NDC 0121-1019

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride (NDC 0121-1019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pharmaceutical Associates, Inc. And Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Buprenorphine Hydrochloride 1)

Chemical Structure (Buprenorphine Hydrochloride 1)
FDA Label Image

Figure (Buprenorphine Hydrochloride 2)

Figure (Buprenorphine Hydrochloride 2)
FDA Label Image

Principal Display Panel (2 mg Sublingual Tablet 30-count Bottle Label)

Principal Display Panel (2 mg Sublingual Tablet 30-count Bottle Label)
FDA Label Image

Principal Display Panel (8 mg Sublingual Tablet 30-count Bottle Label)

Principal Display Panel (8 mg Sublingual Tablet 30-count Bottle Label)